CY1117037T1 - AURISTATIN COGNITIVE PRODUCTS AND USE THEM FOR CANCER, SELF-DIVERSITY OR POLLUTIONAL DISEASE TREATMENT - Google Patents
AURISTATIN COGNITIVE PRODUCTS AND USE THEM FOR CANCER, SELF-DIVERSITY OR POLLUTIONAL DISEASE TREATMENTInfo
- Publication number
- CY1117037T1 CY1117037T1 CY20151101132T CY151101132T CY1117037T1 CY 1117037 T1 CY1117037 T1 CY 1117037T1 CY 20151101132 T CY20151101132 T CY 20151101132T CY 151101132 T CY151101132 T CY 151101132T CY 1117037 T1 CY1117037 T1 CY 1117037T1
- Authority
- CY
- Cyprus
- Prior art keywords
- cancer
- pollutional
- auristatin
- cognitive
- diversity
- Prior art date
Links
Abstract
Αποκαλύπτονται προϊόντα σύζευξης Φαρμάκου-Συνδετικού Μορίου-Συνδετήρα, στα οποία ένα Φάρμακο συνδέεται προς έναν Συνδετήρα μέσω ενός Συνδετικού Μορίου που βασίζεται σε πεπτίδιο. Σε μία πραγματοποίηση, ο Συνδετήρας είναι ένα Αντίσωμα. Επίσης αποκαλύπτονται Ενώσεις Φαρμάκου-Συνδετικού Μορίου και Ενώσεις Φάρμακα. Αποκαλύπτονται επίσης μέθοδοι για θεραπεία καρκίνου, αυτοάνοσης ασθένειας ή μολυσματώδους ασθένειας χρησιμοποιώντας τις ενώσεις και συνθέσεις της εφεύρεσης.Disclosed are Drug-Ligand-Ligand Conjugates, in which a Drug is bound to a Ligand via a peptide-based Ligand. In one embodiment, the Connector is an Antibody. Also disclosed are Drug-Binding Compounds and Drug Compounds. Methods for treating cancer, autoimmune disease or infectious disease using the compounds and compositions of the invention are also disclosed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40040302A | 2002-07-31 | 2002-07-31 | |
EP11165210.3A EP2357006B1 (en) | 2002-07-31 | 2003-07-31 | Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1117037T1 true CY1117037T1 (en) | 2017-04-05 |
Family
ID=58487027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20151101132T CY1117037T1 (en) | 2002-07-31 | 2015-12-10 | AURISTATIN COGNITIVE PRODUCTS AND USE THEM FOR CANCER, SELF-DIVERSITY OR POLLUTIONAL DISEASE TREATMENT |
Country Status (1)
Country | Link |
---|---|
CY (1) | CY1117037T1 (en) |
-
2015
- 2015-12-10 CY CY20151101132T patent/CY1117037T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111894T1 (en) | AURISTATIN COGNITION PRODUCTS AND USE THEM FOR CANCER, SELF-DIVERSITY OR POLYMER DISEASE TREATMENT | |
CY1124166T1 (en) | Antibody Drug Conjugates (ADC) THAT BIND TO 191P4D12 PROTEINS | |
CY1125064T1 (en) | BETA-GLYCURONIDE DRUG CONJUGATIONS | |
CY1118369T1 (en) | CATALOGS AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA | |
CY1117114T1 (en) | HUMANIZED IMMUNOLABLIZED MONOCLONIC ANTIBODIES FOR THE TREATMENT OF TREATMENT IN NEOPLASMAL DISEASE OR IMMUNITY | |
CY1120135T1 (en) | BRUTON TYRUS MOVEMENT SUSPENSIONS | |
CY1111958T1 (en) | ANTI-CSI ANTIBODIES TREATMENT | |
CY1118317T1 (en) | ANTIBODIES CONNECTED TO BLYS | |
NZ754811A (en) | Pyrrolobenzodiazepine-antibody conjugates | |
CY1115076T1 (en) | ANTI-PDGFRα ANTIBODY FOR USE IN TREATMENT OF BREAST METHODS OF BONE | |
CY1112946T1 (en) | 4-HYDROXYBENZOMORPHANIA | |
NO20071585L (en) | New use of peptide compounds for the treatment of bone pain, chemotherapy and nucleoside induced pain | |
DE60321041D1 (en) | ANTIBODY TO CANCERANT TMEFF2 AND ITS APPLICATIONS | |
MX2023002330A (en) | Anti-ceacam5 antibodies and conjugates and uses thereof. | |
CY1110043T1 (en) | 2-AMINOBENZOUL PRODUCTS | |
CY1124183T1 (en) | ANTI-SEZ6 DRUG CONJUGATES AND METHODS OF USE | |
CY1117037T1 (en) | AURISTATIN COGNITIVE PRODUCTS AND USE THEM FOR CANCER, SELF-DIVERSITY OR POLLUTIONAL DISEASE TREATMENT | |
DE60319240D1 (en) | Use of ligands of CD52 antigen for the treatment of solid tumors and bone cancers | |
DK1708693T3 (en) | Pharmaceutical compositions containing platinum complexes with secondary xanthates and therapeutic uses thereof | |
EA202192003A1 (en) | AZETIDOBENZODIAZEPINE DIMERS AND CONJUGATES CONTAINING THEM FOR USE IN CANCER TREATMENT | |
CY1111320T1 (en) | CRIPTO SPECIAL ANTIBODIES | |
CY1114835T1 (en) | COMPLETE HUMAN ANTIBODIES AGAINST HUMAN 4-1B (CD137) |